Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis.

Spagnoli A, Torello M, Nagalla SR, Horton WA, Pattee P, Hwa V, Chiarelli F, Roberts CT Jr, Rosenfeld RG.

J Biol Chem. 2002 May 24;277(21):18860-7. Epub 2002 Mar 8.

2.

Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3.

Phillips LS, Pao CI, Villafuerte BC.

Prog Nucleic Acid Res Mol Biol. 1998;60:195-265. Review.

PMID:
9594576
3.
4.

Potential of proteomics towards the investigation of the IGF-independent actions of IGFBP-3.

Jogie-Brahim S, Min HK, Oh Y.

Expert Rev Proteomics. 2005 Jan;2(1):71-86. Review.

PMID:
15966854
5.
6.

IGFBP-3 and apoptosis--a license to kill?

Butt AJ, Williams AC.

Apoptosis. 2001 Jun;6(3):199-205. Review.

PMID:
11388669
7.

Cartilage disorders: potential therapeutic use of mesenchymal stem cells.

Spagnoli A, Longobardi L, O'Rear L.

Endocr Dev. 2005;9:17-30. Review.

PMID:
15879685
8.

Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3.

Baxter RC, Butt AJ, Schedlich LJ, Martin JL.

Growth Horm IGF Res. 2000 Apr;10 Suppl A:S10-1. Review. No abstract available.

PMID:
10984273
9.

Nuclear actions of insulin-like growth factor binding protein-3.

Baxter RC.

Gene. 2015 Sep 10;569(1):7-13. doi: 10.1016/j.gene.2015.06.028. Epub 2015 Jun 12. Review.

10.

Imposing specificity by localization: mechanism and evolvability.

Ptashne M, Gann A.

Curr Biol. 1998 Nov 5;8(22):R812-22. Review. Erratum in: Curr Biol 1998 Dec 3;8(24):R897.

Supplemental Content

Support Center